Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.69x is 59% above its 5-year average of -4.11x, near the high end of its 5-year range (-110.53x–4.40x).
317.50% below its 12-month average of 0.78x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 4.40x.
INTEREST COVERAGE RATIO
-1.69x
INTEREST COVERAGE RATIO AVG TTM
0.78x
INTEREST COVERAGE RATIO AVG 3Y
-1.31x
INTEREST COVERAGE RATIO AVG 5Y
-4.11x
INTEREST COVERAGE RATIO AVG 10Y
-5.32x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-317.50%
CURRENT VS 3Y AVG
-29.10%
CURRENT VS 5Y AVG
+58.93%
CURRENT VS 10Y AVG
+68.23%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-1.02x
median of 229 covered companies
CURRENT VS SECTOR MEDIAN
-65.69%
vs the sector median at left
Ascendis Pharma A/S
Market Cap
$14.16B
Interest Coverage Ratio
-1.69x
TTM Avg
0.78x
3Y Avg
-1.31x
5Y Avg
-4.11x
Market Cap
$14.79B
Interest Coverage Ratio
N/A
TTM Avg
19.12x
3Y Avg
19.12x
5Y Avg
19.12x
Market Cap
$14.97B
Interest Coverage Ratio
4.74x
TTM Avg
3.27x
3Y Avg
5.51x
5Y Avg
5.84x
Market Cap
$13.19B
Interest Coverage Ratio
N/A
TTM Avg
541.83x
3Y Avg
541.83x
5Y Avg
541.83x
Market Cap
$15.24B
Interest Coverage Ratio
6.29x
TTM Avg
4.55x
3Y Avg
4.55x
5Y Avg
4.55x
Market Cap
$12.95B
Interest Coverage Ratio
-10.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.89B
Interest Coverage Ratio
5.38x
TTM Avg
5.00x
3Y Avg
4.08x
5Y Avg
8.08x
Market Cap
$12.52B
Interest Coverage Ratio
-1.06x
TTM Avg
0.71x
3Y Avg
2.65x
5Y Avg
6.89x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | -1.69x | 0.78x | -1.31x | -4.11x |
| Tempus AI, Inc. (TEM)vs › | $14.64B | -3.60x | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.79B | N/A | 19.12x | 19.12x | 19.12x |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | 4.74x | 3.27x | 5.51x | 5.84x |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | N/A | 541.83x | 541.83x | 541.83x |
| Solventum Corporation (SOLV)vs › | $15.24B | 6.29x | 4.55x | 4.55x | 4.55x |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -10.72x | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 5.38x | 5.00x | 4.08x | 8.08x |
| Baxter International Inc. (BAX)vs › | $12.52B | -1.06x | 0.71x | 2.65x | 6.89x |
| Penumbra, Inc. (PEN)vs › | $12.49B | 144.35x | 102.58x | 62.73x | 62.73x |
Interest Coverage
-1.7x
Debt/Equity
0.31
Current Ratio
2.99
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 4.40x |
| 2026-03-31 | 0.37x |
| 2025-12-31 | 0.16x |
| 2025-09-30 | 0.56x |
| 2025-06-30 | -1.60x |
| 2025-03-31 | -2.33x |
| 2024-12-31 | -0.01x |
| 2024-09-30 | -3.82x |
| 2024-06-30 | -6.79x |
| 2024-03-31 | -0.64x |
| 2023-12-31 | -0.53x |
| 2023-09-30 | -5.48x |
| 2023-06-30 | -15.09x |
| 2023-03-31 | -14.60x |
| 2022-12-31 | -2.06x |
| 2022-09-30 | -3.50x |
| 2022-06-30 | -15.04x |
| 2022-03-31 | -23.71x |
| 2021-12-31 | -2.49x |
| 2021-09-30 | -110.53x |
| 2021-06-30 | -9.69x |
| 2021-03-31 | -143.44x |
| 2020-12-31 | -2.43x |
| 2020-09-30 | -1.97x |
| 2020-06-30 | -8.06x |
| 2020-03-31 | -163.77x |
| 2019-12-31 | -3.14x |
| 2019-09-30 | -146.78x |
| 2019-06-30 | -6.07x |
| 2019-03-31 | -290.11x |
| 2018-12-31 | -2.16x |
| 2018-09-30 | -911.60x |
| 2018-06-30 | -7573.83x |
| 2018-03-31 | -5.02x |
| 2017-09-30 | -11.20x |
| 2017-06-30 | -3.96x |
| 2017-03-31 | -13.68x |
| 2016-09-30 | -51.82x |
| 2016-03-31 | -6.47x |
| 2015-12-31 | -2.16x |
| 2015-09-30 | -26.23x |
| 2015-06-30 | -5.17x |
| 2015-03-31 | -850.89x |
| 2014-12-31 | -17.35x |
| 2014-09-30 | -60.49x |
| 2014-06-30 | -75.17x |
| 2014-03-31 | -14.17x |
